LIGAND PHARMACEUTICALS INC

Historical 13F Holders

CUSIP
53220KAF5
All holders as of
Q2 2023
Type
Debt
Class
NOTE 0.750% 5/1
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2023 Q2 1 300 k $299 k
2023 Q1 27 71.8 M $71.3 M
2022 Q4 26 66.6 M $65.0 M
2022 Q3 24 65.5 M $63.7 M
2022 Q2 24 99.7 M $96.5 M
2022 Q1 31 163 M $162 M
2021 Q4 34 314 M $334 M
2021 Q3 39 322 M $335 M
2021 Q2 44 323 M $356 M
2021 Q1 54 353 M $410 M
2020 Q4 49 475 M $470 M
2020 Q3 49 505 M $465 M
2020 Q2 49 485 M $451 M
2020 Q1 45 500 M $420 M
2019 Q4 51 737 M $639 M
2019 Q3 48 744 M $622 M
2019 Q2 52 741 M $1.59 B